16.9 Evidence Behind the Case

ARRIVED HERE FROM A SEARCH?

If you were looking up one of these, you’re in the right place.

This page belongs to a teaching case built around familial Mediterranean fever (FMF), an IL-1β-driven autoinflammatory disease. If you found it searching a vascular finding, it is a valid, evidence-anchored starting point.

Jump to it:

What this case is

With chronic inflammation simmering, Stina’s vessels aged faster than her birthday: LDL climbing despite a careful diet, a coronary-calcium score too high for a woman her age, and statin muscle aches within weeks. ‘High cholesterolA lipid molecule that is a key component of cell membranes and a precursor for bile acids and steroi and a little calcium — just take a statin and move on.’ Module 16 reads inflammation itself as the risk factor. Stina is me.

Why the logic holds

FMF patients show impaired endothelial function and increased carotid intima-media thickness — subclinical, accelerated atherosclerosis — even when young and normotensive.^1,2 That inflammation is causal, not merely correlated, is the lesson of CANTOS, where blocking IL-1β cut cardiovascular events independent of lipidsOrganic molecules including fats, oils, and steroids.³ (a general trial, but the same IL-1 pathway that runs FMF). FMF also travels with true vasculitis — polyarteritis nodosa and IgA/Henoch-Schönlein.^4,5 And the statin aches are a real, separate drug effect: colchicine plus a statin raises myopathy risk⁶ (callback to Module 7).

Why it’s useful

If you reached this page searching premature atherosclerosis or a high coronary-calcium score in a low-risk patient, FMF vasculitis, or statin intolerance on colchicine, that is the page doing its job: chronic inflammation belongs on the cardiovascular-risk list.